Assessing the Safety and Efficacy of the LAmbre™ Plus Device

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1826 participants.

Also called NCT06465706

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,826 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06465706
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06465706. Randomized; single masking; primary purpose treatment. Start 2024-09-01 (anticipated); primary completion 2029-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessing the Safety and Efficacy of the LAmbre™ Plus Device
Acronym
REDUCE-AF
Intervention (Device)
LAmbre investigational device
Lead sponsor
Kansas City Heart Rhythm Research Foundation (class: other)

Record details

Record id
cardio:ct-nct06465706
Content hash
2dcc8d9221a220f2bcd8ead9f239fc0d156658a6ddcc344182bb792752240ade